Compounds for treating eye disorders or diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10093694
APP PUB NO 20170218009A1
SERIAL NO

15423359

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Described herein are compounds that inhibit or prevent protein aggregation, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with protein aggregation.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GUANGZHOU KANGRUI BIOLOGICAL PHARMACEUTICAL TECHNOLOGIES CO LTD#79 RUIHE ROAD LUOGANG DISTRICT GUANGZHOU 510530

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hou, Rui Guangzhou, CN 138 3201
Li, Gen Guangzhou, CN 272 2156
Zhang, Kang San Diego, US 133 585

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 9, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 9, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00